Association of C-reactive protein levels and long-term survival after neoadjuvant therapy and esophagectomy for esophageal cancer
Date Issued
2010-01-01
Author(s)
DOI
10.1007/s11605-009-1113-2
Abstract
Preoperative C-reactive protein (CRP) levels have been shown to be prognostic markers of survival in patients undergoing esophagectomy for cancer. No study has evaluated the predictive value for survival of CRP levels after neoadjuvant chemoradiotherapy.